Optimization of a Series of RIPK2 PROTACs一系列RIPK2 PROTACs的优化JOURNAL OF MEDICINAL CHEMISTRYIF6.82021-08-2545PREAI
Understanding Pharmacokinetic Disconnect in Preclinical Species for 4-Aminoquinolines: Consequences of Low Permeability and High P-glycoprotein Efflux Ratio on Rat and Dog Oral PharmacokineticsJOURNAL OF PHARMACEUTICAL SCIENCESIF3.82020-10-010OAAI
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel (vol 9, pg 1039, 2018)ACS MEDICINAL CHEMISTRY LETTERSIF42020-06-022OAAI
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2COMMUNICATIONS BIOLOGYIF5.12020-03-20160OAAI
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase InhibitorsACS MEDICINAL CHEMISTRY LETTERSIF42019-10-1114OAAI
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory DiseasesJOURNAL OF MEDICINAL CHEMISTRYIF6.82019-07-0245OAAI
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion ChannelACS MEDICINAL CHEMISTRY LETTERSIF42018-09-2629OAAI
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinaseJOURNAL OF MEDICINAL CHEMISTRYIF6.82016-05-04100PREAI
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase ActivityRIP3诱导凋亡,而与促凋亡激酶活性无关MOLECULAR CELLIF16.62014-11-01540OAAI
Enantioselective Total Synthesis of Brevetoxin A: Unified Strategy for the B, E, G, and J SubunitsCHEMISTRY-A EUROPEAN JOURNALIF3.72009-09-0348OAAI
Silyiene-Mediated Ring Contraction of Homoallylic Ethers To Form Allylic SilanesJOURNAL OF ORGANIC CHEMISTRYIF3.62009-08-1411OAAI